...
首页> 外文期刊>Journal of Medicinal Chemistry >Identification of a novel cardenolide (2 ''-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: Structure-activity relationship analyses
【24h】

Identification of a novel cardenolide (2 ''-oxovoruscharin) from Calotropis procera and the hemisynthesis of novel derivatives displaying potent in vitro antitumor activities and high in vivo tolerance: Structure-activity relationship analyses

机译:鉴定自Calotropis procera的一种新的烯醇内酯(2''-oxovoruscharin)以及半合成的新型衍生物,这些衍生物表现出强大的体外抗肿瘤活性和较高的体内耐受性:结构-活性关系分析

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Analysis of the methanolic extract of Calotropis procera root barks enabled the identification of a novel cardenolide (2"-oxovoruscharin) to be made. Of the 27 compounds that we hemisynthesized, one (23) exhibited a very interesting profile with respect to its hemisynthetic chemical yield, its in vitro antitumor activity, its in vitro inhibitory influence on the Na+/K+-ATPase activity, and its in vivo tolerance. Compound 23 displayed in vitro antitumor activity on a panel of 57 human cancer cell lines similar to taxol, and higher than SN-38 (the active metabolite of irinotecan), two of the most potent drugs used in hospitals to combat cancer.
机译:通过对Calotropis procera根皮的甲醇提取物进行分析,可以鉴定出一种新的烯醇内酯(2”-氧代牛油素)。在我们半合成的27种化合物中,一种(23)在其半合成化学方面表现出非常有趣的概况。化合物23的产量,体外抗肿瘤活性,对Na + / K + -ATPase活性的体外抑制作用及其体内耐受性。化合物23在57种与紫杉醇相似的人类癌细胞系中表现出体外抗肿瘤活性比SN-38(伊立替康的活性代谢产物)要多,后者是医院用于抗癌的两种最有效的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号